MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-24 (biospectator.com)
ENGAIN's Varicose Vein Medical Device Nears Clinical Trial Completion, Poised to Hit Market -
▲young-kanko, CEO of inginin ngain is awaiting the results of the pivotal clinical trial for "venoclo," a varicose vei
Read more
2025-03-23 (cctvplus.com)
Chinese vice premier encourages multinational companies to expand investment in China
Chinese vice premier encourages multinational companies to expand investment in China
Read more
2025-03-06 (massdevice.com)
Medtronic launches extravascular defibrillator in Japan
Medtronic announced that it launched its Aurora EV-ICD system for treating ventricular arrhythmias in Japan.
Read more
2025-03-04 (openpr.com)
Future Business Opportunities in Cerebrospinal Fluid Management Market 2025-2032: Forecast with Growth Analysis By Key Players - Medtronic plc, Integra LifeSciences Corporation
Press release - CoherentMI - Future Business Opportunities in Cerebrospinal Fluid Management Market 2025-2032: Forecast with Growth Analysis By Key Players - Medtronic plc, Integra LifeSciences Corporation - published on openPR.com
Read more
2024-12-05 (biovoicenews.com)
Medtronic launches Percept™ RC rechargeable neurostimulator in India -
Percept™ RC is the smallest and thinnest dual channel rechargeable neurostimulator available for DBS
Read more
2024-11-27 (biovoicenews.com)
Medtronic launches FDA approved InterStim X sacral nerve stimulation therapy in India
The new InterStim X™ Sacral neuromodulation system is a minimally invasive advanced therapy for managing urge urinary incontinence, urinary retention and fecal incontinence
Read more
2024-11-27 (biospectrumindia.com)
Medtronic launches US FDA approved therapy for bladder control and bowel control in India
Medtronic launches US FDA approved therapy for bladder control and bowel control in India
Read more
2024-11-19 (medtechdive.com)
The PFA race is heating up. Here’s where the market stands after J&J’s approval.
Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space as new devices and heart imaging technology hit the market.
Read more
2024-11-14 (topcomunicacion.com)
Medtronic makes visible the reality of living with diabetes
Within the framework of World Diabetes Day, Medtronic launches the #BlueBalloonChallenge for the fourth consecutive year, to raise awareness about the impact of Type 1 Diabetes on people who have to deal in their daily lives with both the symptoms of the pathology as with treatment
Read more
2024-11-14 (consalud.es)
Medtronic launches the #BlueBalloonChallenge for another year to make type 1 diabetes visible
Type 1 diabetes is a pathology that considerably affects people's quality of life. In Spain, it is estimated that more than 16,000 boys and girls have type 1 diabetes
Read more
2024-11-12 (newstrail.com)
Spinal Traction Market Growth Potential is Booming Now: Medtronic, Globus Medical, NuVasive
The Latest Study Published by HTF MI Research on the "Spinal Traction Market’’ evaluates market size, trend and forecast to 2030. The Spinal Traction market
Read more
2024-11-01 (tecnomedicina.it)
Medtronic launches Avalus Ultra valve in Europe
Medtronic announced the European launch of the Avalus valve bioprosthesis […]
Read more